| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/20/2011 | WO2011130304A2 Materials and methods for reliable measurement of blood volume |
| 10/20/2011 | WO2011130301A2 Method of diagnosing and treating melioidosis |
| 10/20/2011 | WO2011130280A1 Products and methods for tissue preservation |
| 10/20/2011 | WO2011130184A2 SYSTEMS AND METHODS FOR MODEL-BASED qPCR |
| 10/20/2011 | WO2011130152A2 Method for identifying hla complexes associated with adverse drug reactions |
| 10/20/2011 | WO2011130080A2 Improved current measurement for water-based mud galvanic electrical imaging and laterlog tools |
| 10/20/2011 | WO2011129844A1 Prognostic markers and methods for prostate cancer |
| 10/20/2011 | WO2011129768A1 A biomarker for renal function in patients with type 2 diabetes |
| 10/20/2011 | WO2011129762A1 Method and kit for cancer diagnosis |
| 10/20/2011 | WO2011129710A1 Microarrays |
| 10/20/2011 | WO2011129685A1 Method for establishing and predicting resistance or responsiveness to chemotherapy using protein profile |
| 10/20/2011 | WO2011129684A1 Method for establishing and predicting resistance or responsiveness to chemotherapy using peptide mass profile |
| 10/20/2011 | WO2011129651A2 Microfluidic device and method for isolating target using same |
| 10/20/2011 | WO2011129649A2 Microfluidic device and method for isolating target using same |
| 10/20/2011 | WO2011129622A2 Microfluidic device |
| 10/20/2011 | WO2011129526A2 Noninvasive method and apparatus for screening high-quality seeds |
| 10/20/2011 | WO2011129494A1 Nucleolin specific aptamer and use thereof |
| 10/20/2011 | WO2011129483A1 Xage-1d marker for diagnosing lung cancer, and diagnostic kit using same |
| 10/20/2011 | WO2011129427A1 Diagnostic agent and therapeutic agent for cancer |
| 10/20/2011 | WO2011129382A1 Methods and reagents for diagnosing rheumatoid arthritis |
| 10/20/2011 | WO2011129371A1 GENE GROUP CAPABLE OF ENHANCING ANTI-TUMOR EFFECT OF 5-FU ALONE OR IFN-α/5-FU COMBINATION |
| 10/20/2011 | WO2011129357A1 Complex of labeled probe and water-soluble carrier |
| 10/20/2011 | WO2011129220A1 Test instrument for measuring analyte in sample, and method for measuring analyte using same |
| 10/20/2011 | WO2011128893A2 Device, system and method for rapid determination of a medical condition |
| 10/20/2011 | WO2011128863A1 Antigenic structure and uses thereof for screening trypanosomiases in humans and animals |
| 10/20/2011 | WO2011128779A1 New methods for isolating tr1 cells |
| 10/20/2011 | WO2011128648A1 Method for identifying quantifiable peptides |
| 10/20/2011 | WO2011128643A1 Method of determining the energy content of a methan - rich gas mixture |
| 10/20/2011 | WO2011128448A1 Method for differentially quantifying naturally processed hla-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development |
| 10/20/2011 | WO2011128357A2 Biomarkers for hypertensive disorders of pregnancy |
| 10/20/2011 | WO2011128324A1 Method for diagnosis of multiple sclerosis involving anti-at1-receptor antibody |
| 10/20/2011 | WO2011128256A1 Metabolic markers for diagnosing of cancer |
| 10/20/2011 | WO2011128079A2 Lacosamide detection assay |
| 10/20/2011 | WO2011127616A1 Diagnostic methods for glaucoma |
| 10/20/2011 | WO2011127615A1 Device for examining contaminated beverages |
| 10/20/2011 | WO2011127587A1 Biomarkers for multiple sclerosis |
| 10/20/2011 | WO2011127585A1 Tumor cell-derived microvesicles |
| 10/20/2011 | WO2011127561A1 Methods and compositions for diagnosing pulmonary fibrosis subtypes and assessing the risk of primary graft dysfunction after lung transplantation |
| 10/20/2011 | WO2011106057A9 Nanostructure biosensors and systems and methods of use thereof |
| 10/20/2011 | WO2011094759A3 Novel diagnostic and therapeutic targets associated with or regulated by n-cadherin expression and/or epithelial to mesenchymal transition (emt) in prostate cancer and other malignancies |
| 10/20/2011 | WO2011091280A3 Methods and systems for analyte measurement |
| 10/20/2011 | WO2011085134A3 Methods and compositions for the diagnosis, prognosis and treatment of cancer |
| 10/20/2011 | WO2011084523A3 Ulk1 compositions, inhibitors, screening and methods of use |
| 10/20/2011 | WO2011072247A8 Pathogen restriction factors |
| 10/20/2011 | WO2011072007A3 Methods and compositions for detection and identification of organophosphorus nerve agents, pesticides and other toxins |
| 10/20/2011 | WO2011071923A3 Multi-sample indexing for multiplex genotyping |
| 10/20/2011 | WO2011068340A3 Synthetic nonionic hydrophilic polymer-based prestained protein size marker |
| 10/20/2011 | WO2011066521A3 Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same |
| 10/20/2011 | WO2011066372A3 Citrullination of human peptidylarginine deiminase 4 (pad-4) regulates its function and immunogenicity |
| 10/20/2011 | WO2011064770A3 Online determination of inter alia fat, protein, lactose, somatic cell count and urea in milk by dielectric spectroscopy between 0.3 mhz and 1.4 ghz using chemometric evaluation |
| 10/20/2011 | WO2011063388A3 Assay method for target nucleic acid by signal amplification using probe hybridization and restriction |
| 10/20/2011 | WO2011056954A3 Haemophilus parasuis polypeptides and methods of use |
| 10/20/2011 | WO2011053907A9 Human omental mesothelial cells, methods of isolation and uses thereof |
| 10/20/2011 | WO2011038158A3 Methods, compositions, systems and apparatus for molecular array fabrication |
| 10/20/2011 | WO2011035177A3 High-throughput screening |
| 10/20/2011 | WO2009143512A3 Compositions and methods relating to detection of soluble e-cadherin in neurodegenerative disease |
| 10/20/2011 | US20110258712 Myostatin isoform |
| 10/20/2011 | US20110258525 System, method, and computer software for linked window interfaces |
| 10/20/2011 | US20110257366 Method for screening candidate compounds for antitumor drug |
| 10/20/2011 | US20110257353 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 10/20/2011 | US20110257223 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
| 10/20/2011 | US20110257146 Method of Treating Kcnq Related Disorders Using Organozinc Compounds |
| 10/20/2011 | US20110257140 Biomarkers of Mineralocorticoid Receptor Activation |
| 10/20/2011 | US20110257043 Ultra high-throughput opti-nanopore dna readout platform |
| 10/20/2011 | US20110257036 Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment Thereof |
| 10/20/2011 | US20110257034 Methods for identifying genes which predict disease outcome for patients with colon cancer |
| 10/20/2011 | US20110257033 Polymer-nanostructure composition for selective molecular recognition |
| 10/20/2011 | US20110257029 Biomarkers for pancreatic cancer and diagnostic methods |
| 10/20/2011 | US20110257028 Method for selectively binding a substrate to sorbents by way of at least bivalent bonds |
| 10/20/2011 | US20110257027 Gamma-secretase substrate and methods of use |
| 10/20/2011 | US20110257023 Methods, systems, and software for identifying functional biomolecules |
| 10/20/2011 | US20110256641 Methods and Systems for Detecting Free IgE |
| 10/20/2011 | US20110256640 Assay for troponin i using magnetic labels |
| 10/20/2011 | US20110256639 Assessment of protein degradation by measurement of isomerised neo-epitope containing fragments |
| 10/20/2011 | US20110256638 Downward or vertical flow diagnostic device and assay |
| 10/20/2011 | US20110256637 Target Detection Using a Single-Stranded, Self-Complementary, Triple-Stem DNA Probe |
| 10/20/2011 | US20110256636 Methods and reagents for diagnosing rheumatoid arthrtis |
| 10/20/2011 | US20110256635 Soluble human st-2 antibodies and assays |
| 10/20/2011 | US20110256634 Sensor measuring method and sensing apparatus |
| 10/20/2011 | US20110256633 Secretory Granules and Granulogenic Factors as a Target for Cancer Treatment |
| 10/20/2011 | US20110256631 Methods and processes for calling bases in sequence by incorporation methods |
| 10/20/2011 | US20110256630 Assay apparatuses, methods and reagents |
| 10/20/2011 | US20110256629 Fully automatic biochemical analyzer and analyzing method thereof |
| 10/20/2011 | US20110256625 Liver Engrafting Cells, Assays, and Uses Thereof |
| 10/20/2011 | US20110256621 Colloidal magnetic nanobioparticles for cytotoxicity and drug delivery |
| 10/20/2011 | US20110256620 Nucleic acid encoding a self-assembling split-fluorescent protein system |
| 10/20/2011 | US20110256582 Method of classifying human subjects having adolescent idiopathic scoliosis (ais) and method for screening for a compound useful in the treatment of ais and related syndromes causing spinal deformities |
| 10/20/2011 | US20110256578 Detection method using nanoaggregate-embedded beads and system thereof |
| 10/20/2011 | US20110256575 Digital sampling apparatus and methods for sorting particles |
| 10/20/2011 | US20110256569 Complex of a chaperone with beta-amyloid and methods employing this complex |
| 10/20/2011 | US20110256563 Method for detecting lysosomal storage diseases |
| 10/20/2011 | US20110256562 Methods for diagnosing heart failure and other cardiac diseases |
| 10/20/2011 | US20110256561 Liver disease marker, method and apparatus for measuring the same, and method for assaying pharmaceutical preparation |
| 10/20/2011 | US20110256560 Methods and compositions for the detection of ovarian cancer |
| 10/20/2011 | US20110256559 Method for Detecting Soluble Amyloid Precursor Protein (APP) Alpha and/or Soluble APP Beta |
| 10/20/2011 | US20110256558 Measuring levels of fibrocystin-l |
| 10/20/2011 | US20110256557 Identifying parathyroid hormone agonists and antagonists |
| 10/20/2011 | US20110256556 Humanized FcgR Mice |
| 10/20/2011 | US20110256555 Use of cxcr4 protein expression on the surface of stem cells as a marker for tumor tropic potential |
| 10/20/2011 | US20110256554 Methods for predicting pregnancy outcome in a subject by hcg assay |